| # | Drug | Count |
|---|---|---|
| 0 | ALENDRONATE SODIUM | 6 |
| 1 | PREDNISONE | 4 |
| 2 | ADALIMUMAB | 3 |
| 3 | ESOMEPRAZOLE MAGNESIUM | 3 |
| 4 | LANSOPRAZOLE | 3 |
| 5 | RITUXIMAB | 3 |
| 6 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 2 |
| 7 | APREPITANT | 2 |
| 8 | ATOVAQUONE | 2 |
| 9 | ATOVAQUONE ORAL SUSPENSION | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ETHAMBUTOL HYDROCHLORIDE | 2 | 0.0007 |
| 1 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 2 | 0.0007 |
| 2 | APREPITANT | 2 | 0.0003 |
| 3 | ATOVAQUONE | 2 | 0.0002 |
| 4 | FEBUXOSTAT TABLETS 40 MG | 2 | 0.0002 |
| 5 | PEGFILGRASTIM | 2 | 0.0002 |
| 6 | CEFAZOLIN SODIUM | 2 | 0.0002 |
| 7 | LOPERAMIDE HCL | 2 | 0.0002 |
| 8 | HEPARIN SODIUM | 2 | 0.0001 |
| 9 | KETOCONAZOLE FOAM | 2 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 4 |
| 1 | CD20-directed Cytolytic Antibody [EPC] | 3 |
| 2 | Proton Pump Inhibitor [EPC] | 3 |
| 3 | Alkylating Drug [EPC] | 2 |
| 4 | Antimalarial [EPC] | 2 |
| 5 | Antiprotozoal [EPC] | 2 |
| 6 | Azole Antifungal [EPC] | 2 |
| 7 | Fluoroquinolone Antibacterial [EPC] | 2 |
| 8 | Leukocyte Growth Factor [EPC] | 2 |
| 9 | Nonsteroidal Anti-inflammatory Drug [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 2 | 0.0002 |
| 1 | Antimalarial [EPC] | 2 | 0.0002 |
| 2 | Antiprotozoal [EPC] | 2 | 0.0002 |
| 3 | Androgen [EPC] | 1 | 0.0000 |
| 4 | Fluoroquinolone Antibacterial [EPC] | 2 | 0.0000 |
| 5 | Leukocyte Growth Factor [EPC] | 2 | 0.0000 |
| 6 | Azole Antifungal [EPC] | 2 | 0.0000 |
| 7 | Xanthine Oxidase Inhibitor [EPC] | 2 | 0.0000 |
| 8 | Anti-IgE [EPC] | 1 | 0.0000 |
| 9 | RANK Ligand Inhibitor [EPC] | 2 | 0.0000 |